NOXOPHARM LIMITED ORDINARY (NOX) Short Interest
NOXOPHARM LIMITED ORDINARY (ASX:NOX) had 0.00% of shares reported as short positions as of 26 June 2026, representing 7,883 shares. NOXOPHARM LIMITED ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
NOX
Noxopharm
Pharmaceuticals, Biotechnology & Life Sciences
Noxopharm Limited is an Australian clinical-stage drug development company focused on creating innovative treatments for cancer and cytokine release syndrome (septic shock). The company is dedicated to improving patient outcomes through novel therapies and has a pipeline of drug candidates targeting unmet medical needs in oncology and inflammation.
Shorted
short percentage0.00%
reported shorts7.9K
shares on issue307.238M